Hepatitis C virus screening and management of seroconversions in hemodialysis facilities

Chukwuma Mbaeyi1, Nicola D Thompson

  • 1Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA. cmbaeyi@cdc.gov

Seminars in Dialysis
|July 18, 2013
PubMed

Insights

Hepatitis C virus (HCV) transmission in hemodialysis facilities is a serious concern. Routine screening for HCV antibodies and strict adherence to infection control are crucial for prevention.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Nephrology

Background:

  • Healthcare-associated hepatitis C virus (HCV) transmission is a significant issue in hemodialysis settings.
  • HCV prevalence is notably higher in hemodialysis patients, leading to increased morbidity and mortality.
  • Outbreaks between 2008-2011 highlighted failures in infection control and screening protocols.

Purpose of the Study:

  • To emphasize the critical need for compliance with national guidelines for HCV antibody (anti-HCV) screening in hemodialysis patients.
  • To outline essential actions for managing potential HCV transmission within hemodialysis facilities.
  • To reinforce infection control practices as key to preventing HCV spread in these units.

Main Methods:

  • Review of national guidelines for anti-HCV screening on admission and semiannually for susceptible patients.
  • Emphasis on early detection through routine screening and timely notification of new infections to public health officials.
  • Assessment of facility-level infection control practices, including medication handling, hand hygiene, and disinfection.

Main Results:

  • HCV outbreaks have occurred due to infection control breaches in hemodialysis facilities.
  • Non-compliance with screening and response guidelines contributes to HCV transmission.
  • Effective management requires routine screening, patient notification, and robust infection control.

Conclusions:

  • Routine anti-HCV screening and strict adherence to infection control are paramount for preventing HCV transmission in hemodialysis units.
  • Early detection and prompt management of new HCV infections are essential.
  • No vaccine exists, making screening and infection control the primary preventive strategies.

Related Concept Videos

Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...